1 / 84

Atrial fibrillation and flutter: Practical Management Tips

Atrial fibrillation and flutter: Practical Management Tips. Internal Medicine Residency Program Noon Conference 2011. Learning Goals. A brief discussion of supraventricular tachycardia (SVT) Review of AF and AFl physiology and EKG differentiation Management of atrial fibrillation (AF)

arien
Download Presentation

Atrial fibrillation and flutter: Practical Management Tips

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Atrial fibrillation and flutter:Practical Management Tips Internal Medicine Residency Program Noon Conference 2011

  2. Learning Goals • A brief discussion of supraventricular tachycardia (SVT) • Review of AF and AFl physiology and EKG differentiation • Management of atrial fibrillation (AF) • Management of atrial flutter (AFl)

  3. Management of fib/flutter • Anticoagulation • Cardioversion • Rate control • Rhythm control • Ablation • Cardiothoracic surgery

  4. But, first, a brief diversion • Definition of supraventricular tachycardia (SVT) • Differentiating among types of SVT • Differentiating AF from AFl

  5. Supraventricular tachycardia • Abbreviated SVT • “Supra” means “above” • Supraventricular tachycardia comes from above the ventricles • DO NOT CONFUSE with NSVT (non-sustained ventricular tachycardia) • (Essentially) all narrow-complex tachycardia has a supraventricular origin

  6. SVT possible sites of origin • Sinus node • Atria • Atrioventricular node • His bundle • Or some combination of the above

  7. Supraventricular tachycardia • Sinus tachycardia • Multifocal atrial tachcyardia • Paroxysmal atrial tachycardia • AV nodal reentrant tachycardia (AVNRT) • Atrioventricular reentrant tachycardia (AVRT) • Atrial fibrillation • Atrial flutter

  8. Rare types of SVT • Inappropriate sinus tachycardia (previously called SNRT or SANRT) • Junctional ectopic tachycardia (JET) and paroxysmal junctional reciprocating tachycardia (PJRT) -- mostly seen in infants and children • Nonparoxysmal junctional tachycardia (NPJT) -- seen in acute right coronary artery occlusion and digitalis toxicity

  9. Supraventricular tachycardia • A nonspecific term that technically refers to seven separate diagnoses • When clinicians use the term “SVT,” they mean that it is a narrow-complex tachycardia, and they cannot specify which one • Do not use the term “SVT” if you have an actual diagnosis • Do use “SVT” when the patient has “supraventricular tachycardia, not otherwise specified”

  10. Supraventricular tachycardia • Sinus tachycardia • Multifocal atrial tachcyardia • Paroxysmal atrial tachycardia • AV nodal reentrant tachycardia (AVNRT) • AV reentrant tachycardia (AVRT) • Atrial fibrillation • Atrial flutter

  11. When in doubt, use a vagal maneuver • Adenosine 6mg IV push -We don’t use enough adenosine! -But must be done with proper monitoring • Valsalva maneuver -Safe; usually ineffective • Carotid sinus massage -In properly selected populations, complications are rare

  12. Carotid Sinus Massage Contraindications • Carotid bruit • Prior stroke or transient ischemic attack, unless imaging has shown no significant carotid disease • Myocardial infarction in the previous six months • History of serious cardiac arrhythmias (VT, VF)

  13. Vagal maneuvers • Diagnostic -Usually you can learn which SVT it was by doing a vagal maneuver • Therapeutic -Vagal maneuvers can terminate AVRT and AVNRT

  14. Differentiating AF from AFl • AFl is a macroreentrant atrial rhythm with a reentry circuit that involves a large area of atrial myocardium • AF is caused by multiple wandering wavelets, a hodgepodge of microreentrant circuits, often located in the pulmonary veins

  15. Atrial flutter

  16. Atrial flutter • P waves exhibit a “sawtooth” pattern referred to as flutter waves or “F” waves • Atrial rate is typically 250-350 beats per minute (bpm)

  17. Atrial flutter, continued • Classically, atrial rate is 300 bpm with 2:1 AV conduction, leading to a heart rate of 150 bpm • But focus on the atrial pattern when diagnosing SVT--try to ignore the QRS complexes, just looking at the P (or F) waves at first

  18. Atrial flutter (with 4:1 response)

  19. Atrial flutter (with 2:1 response)

  20. Atrial flutter (variable response)

  21. Atrial flutter (and more)

  22. AF diagram

  23. Atrial fibrillation • Rapid and irregular atrial activity at a rate of 350-600 impulses per minute • Usually irregularly irregular ventricular response • There are no P waves • Sometimes the F waves are so fine, the surface EKG cannot detect them

  24. Atrial fibrillation

  25. Atrial fibrillation

  26. Atrial fibrillation terms • Paroxysmal • Persistent • Permanent • “Lone”

  27. Atrial fibrillation terms, cont. • Paroxysmal -episodes terminate spontaneously in less than seven days • Persistent -fails to terminate within seven days

  28. Atrial fibrillation terms, cont. • Permanent -AF lasts for more than one year, and -Cardioversion has not been attempted or has failed • “Lone” -patients less than 60 years of age without structural heart disease

  29. Atrial fibrillation terms, cont. • This classification applies only when no clear reversible cause of AF. • If AF is clearly due to heart surgery, pericarditis, myocardial infarction, hyperthyroidism, pulmonary embolism, or other reversible causes, avoid this classification system

  30. Management of fib/flutter • Anticoagulation • Cardioversion • Rate control • Rhythm control • Ablation • Cardiothoracic surgery

  31. Anticoagulation (AC) • Recommendations are essentially the same for AF and AFl • First, assess if the patient is high risk for cardioembolic stroke • Most patients with high risk should be on AC if they ever were seen in AF or AFl

  32. High risk for cardioembolic stroke • Rheumatic mitral stenosis -Mitral valve area less than 2.0 cm2 • Prosthetic heart valves • Hyperthyroid (?) -2006 ACC/AHA/ESC guidelines recommend INR 2-3 in all patients until euthyroid; ACCP does not comment on this

  33. CHADS2 score • For use in patients without the high risk factors on the previous slide • There are other risk models, including the CHADS2-VASc score

  34. CHADS2 score

  35. When can you stop AC? • If AF was due to a completely reversed reversible cause, maybe you can stop • For AFl, you can never stop • After ablation you still can’t stop • If you had HF, and your EF returns to normal, you still can’t stop • Paroxysmal has same risk as others

  36. When to stop AC • Pretty much you have to develop a contraindication to anticoagulation before you stop it • Fall risk is a relative contraindication; it’s rare that someone is falling so frequently that it rises to the level of contraindication

  37. When to stop AC • Really, paroxysmal AF has same stroke risk as other AF • Caution when diagnosing AF! If you misdiagnosed NSR with PAC’s or multifocal atrial tachycardia as AF, you can doom someone to lifelong AC

  38. When to bridge with heparin • If patient has any evidence of hypercoagulable state • If patient has prosthetic heart valves • Otherwise, risk of intracranial bleeding and HIT outweighs benefit of reduced stroke risk and warfarin skin necrosis

  39. Risk of stroke per day off AC • Less than 4 events per 100 person-years prevented • One day is 4/100/365=0.0011% per day stroke risk reduction Efficacy and safety of anticoagulant treatment in acute cardioembolic stroke: a meta-analysis of randomized controlled trials. Paciaroni M, Agnelli G, Micheli S, Caso VS. Stroke. 2007;38(2):423.

  40. What about asa+clopidogrel?

  41. Active-A continued—bleeding

  42. Take-home point • Warfarin>ASA+clopidogrel>ASA • This applies to stroke prevention • And to bleeding risk • Every AF patient who is off warfarin should be on aspirin unless there is a contraindication to ASA therapy

  43. Clopidogrel + Warfarin = Bleed • ASA+warfarin and ASA+clopidogrel are relatively safe in most situations where both are indicated • Warfarin+clopidogrel has a relative risk of bleeding >3 times greater than warfarin alone • ASA+warfarin+clopidogrel has less rigorous data; evidence suggests >5 times greater than asa+clopidogrel alone

  44. Dabigatran and Apixaban • Oral anticoagulant medications that do not require monitoring • Dabigatran approved for AC in AF/AFl in USA; NYS Medicaid and NBHN do not pay for it. Medicare part D does pay • Apixaban likely similar; not yet approved

  45. You’re the night intern • 78 W with HTN, DM, COPD, and history of paroxysmal AF • Nurse pages you to say that HR is now 172 beats per minute after albuterol • You ask, “what’s the blood pressure?” • The nurse says she will check. You go to the bedside.

  46. You’re the night intern • HR=172 irregular, BP is 72/48 • Pt. is pale, diaphoretic, lethargic but responds to questions • You confirm with EKG that the rhythm is atrial fibrillation • Put patient in Trendelenberg position to optimize cerebral perfusion, then you…

  47. Single best answer: Next step • A) DC cardioversion without sedation • B) Ativan 2mg IV over 30 seconds, then direct current (DC) cardioversion • C) Amiodarone 150mg IV over 15 min. • D) Diltiazem 10mg IV over 2 minutes • E) Adenosine 6mg IV push

More Related